CDRC 2021 Annual Meeting: Propanolol in Angiosarcoma- the story so far

CDRC 2021 Annual Meeting: Repurposing- Case StudyПодробнее

2021 CDRC Annual Meeting Day 1 - Session 2Подробнее

Propranolol and Cancer Cells ResearchПодробнее

Clinical Trial: BI 765179 for Tumors (NCT04958239)Подробнее

Dr. Hope Rugo Examines Angiogenesis Inhibition for Advanced Breast CancerПодробнее

Dr. Mathieu D'Hondt - PRESENTATION (2024): The Inherent Stability of Robotic VisionПодробнее

Sarcoma Treatment with Targeted Therapies: PropranololПодробнее

CDRC 2021 Annual Meeting: The Pediatric Trials Networks experienceПодробнее

Introduce “what is angiosarcoma .”About the survival time and best practice.Подробнее

Prevalence of anemia among CKD patients - Video abstract [ID 216010]Подробнее

Dr. Hammers on the CheckMate-214 Study for RCCПодробнее

A.Chalapas | TAVR in patients with end-stage CKD or οn renal replacement therapy: Special consid...Подробнее

Dr. Andtbacka on Ongoing Trials with Oncolytic Immunotherapies in MelanomaПодробнее

Vascular tumors (kaposi, hemangioma, angiosarcoma) - Causes & SymptomsПодробнее

Pharmacodynamic correlates and ctDNA dynamics in the NeoCOAST studyПодробнее

VCCN Cancer Care Never Stops GP 6 (no captions)Подробнее

2017 CCF Annual Conference #5 - Day 1 - SurgeryПодробнее

Benefits of Combining Beta-Blocker and Checkpoint InhibitorПодробнее